Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against aTyr Pharma, Inc. due to allegations of misleading statements regarding the efficacy of its drug Efzofitimod, which led to significant financial losses for investors [2][4]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in aTyr between January 16, 2025, and September 12, 2025, to discuss their legal rights [1]. - There is a deadline of December 8, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against aTyr [2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [3]. Group 2: Allegations Against aTyr - The complaint alleges that aTyr and its executives violated federal securities laws by making false and misleading statements about Efzofitimod, particularly regarding its ability to allow patients to taper off steroid usage [4]. - In the EFZO-FIT study, efzofitimod showed no significant change in mean daily oral corticosteroid (OCS) dose at week 48, with a reduction of 2.79 mg for the drug compared to 3.52 mg for placebo [5]. - The study reported that complete steroid withdrawal was achieved in 52.6% of patients treated with efzofitimod versus 40.2% on placebo [5]. Group 3: Market Impact - Following the release of the study results, aTyr's stock price plummeted by 83.25%, dropping from a market close of $6.03 on September 12 to $1.01 on September 15 [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against DeFi Technologies Inc. and reminds investors of the January 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit against the company [2][4]. Group 1: Allegations Against DeFi Technologies - The complaint alleges that DeFi Technologies and its executives violated federal securities laws by making false and misleading statements regarding delays in executing its DeFi arbitrage strategy, which is a key revenue driver [4]. - It is claimed that DeFi Technologies understated the competition it faced from other digital asset trading (DAT) companies, which negatively impacted its ability to execute its arbitrage strategy [4]. - The company was unlikely to meet its previously issued revenue guidance for fiscal year 2025 due to these issues, which were downplayed in public statements [4]. Group 2: Financial Performance and Stock Impact - On November 6, 2025, DeFi Technologies reported a significant decline in its stock price by $0.13 per share, or 7.43%, closing at $1.62 per share following a press release about an arbitrage trade [5]. - Following the release of its third-quarter financial results on November 14, 2025, the company reported a revenue decline of nearly 20%, falling short of market expectations, and significantly lowered its 2025 revenue forecast from $218.6 million to approximately $116.6 million [6]. - After these disclosures, DeFi Technologies' stock price fell by $0.40 per share, or 27.59%, closing at $1.05 per share on November 17, 2025 [7].

Core Viewpoint - Firefly Aerospace is facing a class action lawsuit due to allegations of misleading statements regarding its business operations and financial performance, with a lead plaintiff deadline set for January 12, 2026 [2][4]. Company Overview - Firefly Aerospace conducted its initial public offering (IPO) on August 7, 2025, selling 19.296 million shares at a price of $45.00 per share [5]. - The company reported a significant loss of $80.3 million, or $5.78 per share, for Q2 2025, which was an increase from a loss of $58.7 million, or $4.60 per share, in the same quarter of 2024 [6]. Financial Performance - Firefly's revenue for Q2 2025 was $15.55 million, falling short of analyst expectations of $17.25 million and representing a 26.2% decrease year-over-year [6]. - The Spacecraft Solutions business segment reported revenue of only $9.2 million, indicating a 49% year-over-year decline [6]. Stock Performance - Following the Q2 earnings report, Firefly's stock price dropped by $7.58, or 15.31%, closing at $41.94 on September 23, 2025 [7]. - After the announcement of a failed rocket test on September 29, 2025, the stock price fell further by $7.66, or 20.73%, closing at $29.30 on September 30, 2025 [9]. Legal Proceedings - The lawsuit alleges that Firefly and its executives violated federal securities laws by making false or misleading statements about the demand for its Spacecraft Solutions and the operational readiness of its Alpha rocket program [4]. - Investors who purchased Firefly securities during the class period from August 7, 2025, to September 29, 2025, are encouraged to discuss their legal rights with the law firm Faruqi & Faruqi [2][10].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against StubHub Holdings, Inc. and reminds investors of the January 23, 2026 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit against the company [2][4]. Group 1: Legal Action and Investor Information - A class action lawsuit has been filed against StubHub, alleging that the company's registration statement was materially false and misleading, failing to disclose significant adverse facts about its business and operations [4]. - Investors who purchased StubHub stock during its IPO on September 17, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights [1][2]. - The lead plaintiff in the class action will be the investor with the largest financial interest who is typical of class members, and any member of the class can move to serve as lead plaintiff [9]. Group 2: Financial Performance and Stock Impact - StubHub's IPO on September 17, 2025, involved the sale of approximately 34 million shares at $23.50 per share [5]. - The company reported a free cash flow of negative $4.6 million for Q3 2025, a 143% decrease from the previous year's positive free cash flow of $10.6 million [6]. - Following the release of disappointing financial results, StubHub's stock price fell by $3.95 per share, or 20.9%, closing at $14.87 on November 14, 2025, with the stock trading as low as $10.31 per share by the time of the lawsuit, representing a nearly 56% decline from the IPO price [7][8].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against CarMax, Inc. and reminds investors of the January 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit against the company [2][4]. Group 1: Allegations and Financial Impact - The complaint alleges that CarMax and its executives violated federal securities laws by making false and misleading statements regarding the company's growth prospects, which were overstated due to temporary benefits from customer behavior related to tariff speculation [4]. - Following the release of CarMax's second quarter fiscal 2026 financial results, which included an 11.2% decrease in CarMax Auto Finance income and a provision for loan losses of $142.2 million, the company's stock price fell by approximately 20%, closing at $45.60 per share on September 26, 2025 [5]. Group 2: Legal Proceedings and Participation - The lead plaintiff in the class action lawsuit is defined as the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [6]. - Faruqi & Faruqi encourages anyone with information regarding CarMax's conduct, including whistleblowers and former employees, to contact the firm [7].

Core Viewpoint - Faruqi & Faruqi LLP is investigating potential claims against Freeport-McMoran Inc. related to a federal securities class action lawsuit, with a lead plaintiff deadline set for January 12, 2026 [2][4]. Group 1: Legal Proceedings - The lawsuit alleges that Freeport and its executives violated federal securities laws by making false or misleading statements and failing to disclose safety issues at the Grasberg Block Cave mine in Indonesia [4]. - The complaint highlights that inadequate safety measures posed a heightened risk of worker fatalities, which was not disclosed to investors [4]. - Investors who purchased Freeport securities between February 15, 2022, and September 24, 2025, are encouraged to discuss their legal rights with the firm [2][4]. Group 2: Incident Impact - On September 9, 2025, Freeport suspended mining activities at the Grasberg Block Cave after a significant incident trapped seven workers, leading to a stock price drop of $2.77 (5.9%) to $43.89 per share [5]. - Following the tragic update on September 24, 2025, where two workers were confirmed dead, Freeport's stock fell by $7.69 (17%) to close at $37.67 per share [6]. - An article published on September 25, 2025, indicated that the halt in production could strain Freeport's relationship with the Indonesian government, resulting in a further stock decline of $2.33 (6.2%) to $35.34 [7]. Group 3: Expert Opinions and Future Actions - An expert stated that the landslide incident at Freeport was preventable and should have been anticipated, raising concerns about the company's operational safety [8]. - The firm encourages anyone with information regarding Freeport's conduct, including whistleblowers and former employees, to come forward [9].

Core Viewpoint - Faruqi & Faruqi LLP is investigating potential claims against Bitdeer Technologies Group, reminding investors of the February 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit against the company [2][4]. Group 1: Legal Action and Investor Information - The class action lawsuit alleges that Bitdeer and its executives violated federal securities laws by making false or misleading statements regarding the efficiency and readiness of their SEALMINER A4 rigs and SEAL04 ASIC chip technology [4]. - Investors who purchased Bitdeer securities between June 6, 2024, and November 10, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights [1][2]. - The lead plaintiff in the class action will be the investor with the largest financial interest who is typical of class members, and any member can move to serve as lead plaintiff [7]. Group 2: Financial Performance and Stock Impact - On November 10, 2025, Bitdeer reported a third-quarter earnings per share of -$1.28, missing the consensus estimate of -$0.22, and disclosed significant delays in the development of its next-generation Seal 04 ASIC chip [5]. - Following this announcement, Bitdeer's stock price fell by $2.63, or 14.9%, closing at $15.02 per share on November 11, 2025 [5]. - A subsequent fire incident at Bitdeer's under-construction facility in Ohio on November 11, 2025, led to an additional stock price drop of $2.83, or 20.3%, closing at $11.11 per share on November 13, 2025 [6].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avantor, Inc. due to allegations of misleading statements regarding the company's competitive positioning and financial performance during a specified class period [2][4]. Group 1: Allegations and Misleading Statements - The complaint alleges that Avantor and its executives violated federal securities laws by making false and misleading statements about the company's competitive position and the impact of increased competition [4]. - During an earnings call on July 26, 2024, Avantor's then-CEO assured investors of the company's strong competitive position, despite evidence to the contrary [5]. - The company downplayed the effects of increased competition, which later contributed to disappointing financial results [6]. Group 2: Financial Performance and Stock Price Impact - On April 25, 2025, Avantor reported disappointing Q1 2025 results, cutting its guidance and announcing the CEO's resignation, leading to a stock price decline of over 16.5% [6][7]. - The company continued to report weak financial results in Q2 2025, with a further reduction in guidance, resulting in a stock price drop of more than 15% [6][8]. - In Q3 2025, Avantor reported a net loss of $712 million and -5% organic revenue growth, attributed to competitive pressures, causing a stock price decline of over 23% [8].

Core Viewpoint - Baxter International Inc. is facing a federal securities class action lawsuit due to allegations of making false and misleading statements regarding the safety and efficacy of its Novum LVP product, which has been linked to serious patient risks [4][5]. Group 1: Legal Proceedings - Faruqi & Faruqi, LLP is investigating potential claims against Baxter and reminds investors of the December 15, 2025 deadline to seek the role of lead plaintiff in the class action lawsuit [2]. - The lawsuit alleges that Baxter and its executives violated federal securities laws by failing to disclose systemic defects in the Novum LVP, which led to malfunctions and risks to patient safety [4]. - The lead plaintiff in the class action will be the investor with the largest financial interest who is typical of class members, and any member can move to serve as lead plaintiff [6]. Group 2: Financial Impact - The true extent of the alleged fraud was revealed on July 31, 2025, when Baxter announced a voluntary pause in shipments and installations of the Novum LVP, resulting in a 22.4% drop in stock price, closing at $21.76 [5]. - Baxter was reportedly aware of multiple device malfunctions and injuries related to the Novum LVP but failed to take adequate remedial measures [4]. Group 3: Company Background - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its founding in 1995 and has offices in New York, Pennsylvania, California, and Georgia [3]. - The firm encourages anyone with information regarding Baxter's conduct to come forward, including whistleblowers and former employees [7].

Core Viewpoint - Blue Owl Capital Inc. is facing a federal securities class action lawsuit due to allegations of misleading statements and undisclosed liquidity issues, with a lead plaintiff deadline set for February 2, 2026 [2][4]. Company Overview - Blue Owl Capital Inc. is under investigation for potential claims related to violations of federal securities laws, specifically regarding misleading statements about its asset base and liquidity [2][4]. - The company has been reported to block redemptions in one of its private credit funds, which could lead to significant losses for investors [5]. Financial Impact - Following the announcement of the merger and the blocking of redemptions, Blue Owl's stock price dropped by $0.85, or 5.8%, closing at $13.77 per share on November 17, 2025 [6]. - Investors in Blue Owl Capital Corporation II will lose the ability to redeem cash at the fund's Net Asset Value (NAV) after the merger, with current trading approximately 20% under the fund's NAV [6]. Legal Proceedings - The lawsuit alleges that Blue Owl and its executives failed to disclose critical information regarding BDC redemptions and liquidity issues, which misled investors about the company's operational health [4]. - The role of the lead plaintiff is crucial as it represents the investor with the largest financial interest in the case, who will oversee the litigation on behalf of the class [7]. Call to Action - Faruqi & Faruqi, LLP is encouraging investors who suffered losses to contact them for discussions about their legal rights and options [1][2].